Prostate Health Market, by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global Prostate Health market size is projected to reach USD 48.6 billion by 2026 at a CAGR of 9.1% from USD 31.9 billion in 2021 during the forecast period 2021-2028.
Prostrate is a gland in the human male reproductive system which is shaped like a walnut. It is located below the bladder and surrounds the urethra. Its basic size increase with increasing age but if the increase is more then it may result in the compression of the urethra leading to the non-passage of the urine.
Increased incidents of prostate cancer along with rising problem of obesity are some of the factors that have supported long-term expansion for Prostate Health Market.
The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. Due to the unfavourable policies and regulations the market has witnessed a sharp decline.
North America is expected to be the largest market of during the forecast period. The increasing population long with the increased incidents o BPH and prostate cancer and the high disposable income and rapid development in healthcare has led to the expansion of market in the region.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 31.9 billion |
Growth Rate |
CAGR of 9.1% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD million and CAGR from 2021 to 2028 |
Report Segmentation |
Disease indication and geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc. , GlaxoSmithKline plc. , Abbott , and Astellas Pharma Inc. |
Available Customization |
In addition to the market data for Prostate Health Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Prostate Health Market is segmented into Disease Indication and geography.